• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 4. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

Ethyl 5-Bromonicotinate 1-oxide (CAS No. 279248-42-9): A Comprehensive Overview in Modern Chemical Biology

Ethyl 5-Bromonicotinate 1-oxide (CAS No. 279248-42-9) is a specialized organic compound that has garnered significant attention in the field of chemical biology due to its unique structural properties and potential applications. This compound, characterized by its brominated nicotinate backbone and an oxide functional group, represents a fascinating subject of study for researchers exploring novel synthetic pathways and biological interactions.

The molecular structure of Ethyl 5-Bromonicotinate 1-oxide encompasses a pyridine ring substituted with a bromine atom at the 5-position and an ester group linked to an alcohol oxidized to an oxide. This configuration imparts distinct reactivity, making it a valuable intermediate in the synthesis of more complex molecules. The presence of the bromine atom enhances its utility in cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are pivotal in constructing intricate organic frameworks.

In recent years, the pharmaceutical industry has shown increasing interest in halogenated nicotinates due to their versatile pharmacological profiles. Studies have demonstrated that compounds featuring a brominated pyridine core exhibit potent activity against various biological targets, including enzymes and receptors involved in metabolic disorders and inflammatory diseases. The oxide moiety in Ethyl 5-Bromonicotinate 1-oxide further contributes to its biological significance by influencing electron distribution and reactivity, enabling selective modifications at key positions within the molecule.

One of the most compelling aspects of Ethyl 5-Bromonicotinate 1-oxide is its role as a precursor in the development of novel therapeutic agents. Researchers have leveraged its reactivity to design derivatives with enhanced binding affinity and reduced toxicity. For instance, modifications at the ester group have been explored to improve solubility and metabolic stability, while strategic functionalization of the pyridine ring has yielded compounds with targeted action against specific disease pathways.

The synthesis of Ethyl 5-Bromonicotinate 1-oxide presents an intriguing challenge due to the need for precise control over regioselectivity and stereoselectivity. Advanced synthetic methodologies, including transition-metal-catalyzed reactions and organometallic chemistry, have been employed to achieve high yields and purity. These techniques not only highlight the compound's synthetic utility but also underscore the evolving capabilities of modern organic synthesis.

Recent advancements in computational chemistry have further illuminated the potential of Ethyl 5-Bromonicotinate 1-oxide as a scaffold for drug discovery. Molecular modeling studies have identified optimal binding orientations within biological targets, providing insights into how structural modifications can fine-tune pharmacological activity. Such computational approaches are increasingly integral to rational drug design, enabling researchers to predict and optimize molecular interactions with unprecedented precision.

The versatility of Ethyl 5-Bromonicotinate 1-oxide extends beyond pharmaceutical applications. Its unique reactivity has been exploited in materials science, where it serves as a building block for advanced polymers and functional materials. The ability to incorporate brominated nicotinates into larger molecular frameworks has led to the development of novel materials with enhanced electronic properties, making them suitable for use in optoelectronic devices and sensors.

As research continues to uncover new applications for halogenated nicotinates, Ethyl 5-Bromonicotinate 1-oxide is poised to remain at the forefront of chemical innovation. Its role as a versatile intermediate and precursor underscores its importance in both academic research and industrial development. By leveraging its unique structural features, scientists are paving the way for breakthroughs across multiple disciplines, from medicine to materials science.

• 35150-06-2(N-(tert-Butoxycarbonyl)-L-phenylalaninamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)